AKT3 was up-regulated in the Epstein-Barr virus infected cancers progression, such as the proliferation of malignant cells or lymphocytes and immune escape, which might be triggered by EBV-encoded proteins LMP1 and LMP2 in the NPC17. This evidence concerns the gene AKT3 and cancer.